Immunoediting and Antigen Loss: Overcoming the Achilles Heel of Immunotherapy with Antigen Non-Specific Therapies
Cancer immunotherapy has emerged as a mainstream therapy option in the battle against cancer. Pre-clinical data demonstrates the ability of immunotherapy to harness the immune system to fight disseminated malignancy. Clinical translation has failed to recapitulate the promising results of pre-clin...
Main Authors: | Arta Monir Monjazeb, Anthony E Zamora, Steven K Grossenbacher, Annie eMirsoian, Gail D Sckisel, William J Murphy |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00197/full |
Similar Items
-
Abnormally primed CD8 T cells: The Achilles’ heel of CHB
by: Xiaoqing Chen, et al.
Published: (2023-03-01) -
Differential phenotypes of memory CD4 and CD8 T cells in the spleen and peripheral tissues following immunostimulatory therapy
by: Gail D. Sckisel, et al.
Published: (2017-04-01) -
Exosomes in cancer immunoediting and immunotherapy
by: Yarong Zhao, et al.
Published: (2022-03-01) -
Tumor-Derived Extracellular Vesicles in Cancer Immunoediting and Their Potential as Oncoimmunotherapeutics
by: Meysam Najaflou, et al.
Published: (2022-12-01) -
Editorial: Radiation and the Immune System: Current Knowledge and Future Perspectives
by: Katalin Lumniczky, et al.
Published: (2018-01-01)